Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2018-06-04 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) from Novozymes detailing the specific transactions of their share buyback program over a one-week period (May 28 to June 1, 2018). It includes a summary table of the buybacks and a detailed appendix of every individual trade executed by Danske Bank. This falls under the category of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares in accordance with market abuse regulations.
2018-06-04 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a short announcement regarding transactions related to a share buyback program ('aktietilbagekøbsprogram'). It directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, since this is a short announcement of a transaction rather than the full report itself, and specifically concerns the company buying back its own shares, it is classified as a Transaction in Own Shares (POS).
2018-06-04 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled 'Stock Buybackprogram'. This indicates the document is an announcement about a transaction (stock buyback) rather than the detailed report itself. Since the core activity is the company transacting in its own shares, the most specific category is 'Transaction in Own Shares' (POS). However, given the 'MENU VS MEAL' rule, if the document is just an announcement pointing to the full details, it could be RPA or RNS. Since 'POS' specifically covers share repurchase/issuance reports, and this is an announcement *about* those transactions, I must check if POS covers the announcement or just the filing. Given the options, POS is the most specific fit for the *subject matter* (share repurchase). If the subject matter was not covered, RPA would be the choice for an announcement. Since POS covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)', and this is an announcement of those transactions, I will classify it as POS, assuming the announcement itself is filed under this category, or if it were longer, it would be the filing itself. Given the brevity and the nature of the announcement, RPA (Report Publication Announcement) is also a strong candidate, but POS is the subject matter. I will prioritize the subject matter (POS) over the announcement format (RPA) because the subject is highly specific, and the document is clearly about share repurchase activity.
2018-05-28 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (427 characters) and is written in Danish. The title translates to 'Transactions related to Novozymes' share buyback program'. The body explicitly states, 'Læs venligst hele meddelelsen i vedhæftede fil' (Please read the entire announcement in the attached file) and provides a link to a document titled 'Stock_Buybackprogram_DK'. This structure—a very brief announcement pointing to an attached/linked document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content specifically relates to the company buying back its own shares, the most precise category is 'Transaction in Own Shares' (POS). However, given the 'MENU VS MEAL' rule, if this is just the announcement of the transaction details (which are in the linked file), it should be RPA. Since POS is a specific category for buybacks, and this document is clearly announcing the details of those transactions, I will classify it as POS, assuming the announcement itself is the primary filing type, even if details are linked, as it is more specific than RPA. If the linked file contained the actual transaction log, this announcement would be RPA. Given the context of 'Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram', POS is the best fit for the subject matter.
2018-05-28 Danish
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of transactions related to Novozymes' share buyback program, including the number of shares repurchased, transaction values, and dates. It references the share repurchase program initiated in 2018 and provides detailed trading data. There is no indication that this is a full financial report, earnings release, or management discussion. The content focuses on the company's repurchase of its own shares, which fits the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, not just a brief announcement or a report publication notice. Therefore, the appropriate classification is POS with high confidence.
2018-05-28 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including number of shares purchased, transaction values, and dates. It references compliance with Market Abuse Regulation and provides detailed trading data. There is no indication of financial statements, management discussion, or earnings data. The content is focused on the company's repurchase of its own shares, which fits the category of a share repurchase or issuance transaction. The document length is substantial and contains detailed transaction data, not just a brief announcement or a report publication notice. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2018-05-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.